EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
FocalTherics announced that CEO Ryan Rhodes is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 15, 2026.
CFO Ken Mobeck will join management to host one-on-one investor meetings with attendees on Tuesday and Wednesday, September 15-16.
A live and archived webcast of the presentation will be accessible via the Investors section of the company's website.